218.80 € resistance breached: Sartorius Stedim Biotech stock holds firm
The bioprocess specialist extends its mid-session recovery in a well-oriented Paris market. The stock climbs above a technical threshold that has been closely monitored for several weeks and consolidates above its three moving averages.
218.80 € resistance breached and sustained during the session, above moving averages
The Sartorius Stedim Biotech share gains 2.53% to 219 €, after breaking through its 218.80 € resistance level upward and holding above it. The movement extends the rebound initiated last Friday, as the stock advances 15.69% over three months. The price stands 4.66% above its 20-day moving average and 11.83% above its 50-day moving average, which positions the rise within an established trend rather than a mere spike.
The stock thus gains 2.53% while the SBF 120 advances 0.61% and the CAC 40 rises 0.62%. It ranks among the strongest gainers of the SBF 120. The RSI at 59 still leaves room before the overbought zone.
Half-year results published on July 22 and a stock trading at nearly 44 times earnings
Upon the publication of first-half 2026 results on July 22, the group set a revenue trajectory of 3,153.8 million euros for the following fiscal year. Based on expected earnings per share according to the consensus of surveyed analysts, the stock is trading at approximately 43.9 times the earnings of the current fiscal year and 36.4 times those of the following fiscal year. The stock displays 17.05% gain over one year and 17.17% over one month. The next technical target to monitor is the support level at 184 €, while the resistance that has just been breached becomes the reference level for the coming sessions.
